| Literature DB >> 25311752 |
Anna Skarpańska-Stejnborn1, Piotr Basta, Jerzy Trzeciak, Łucja Szcześniak-Pilaczyńska.
Abstract
PURPOSE: Physical exercise, especially intense physical exercise, causes a number of unfavorable changes, including an increase in the level of pro-inflammatory cytokines with the resultant sequestration of iron in macrophages and decreased iron absorption. This can lead to a reduced supply of iron for erythroid progenitor cells and promote the development of anemia.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25311752 PMCID: PMC4289533 DOI: 10.1007/s00421-014-3018-3
Source DB: PubMed Journal: Eur J Appl Physiol ISSN: 1439-6319 Impact factor: 3.078
Basic characteristics of the study participants (means ± standard deviations)
| Parameters |
|
|---|---|
| Age, years | 21.3 ± 0.82 |
| Body mass, kg | 87.7 ± 9.63 |
| Body height, m | 1.91 ± 0.06 |
| Duration of training, years | 7.2 ± 1.3 |
Power output, blood lactic acid levels, and total run time (means ± standard deviations)
| Parameters |
|
|---|---|
| Power, watts | 430 ± 34.1 |
| W/kg | 4.88 ± 0.28 |
| LAmin, mmol/L | 1.6 ± 0.14 |
| LAmax, mmol/L | 14.9 ± 2.62 |
| Time, s | 373.4 ± 10.38 |
Training schedule during the 3 days preceding blood sample collection
| Days before ergometer test | ||||
|---|---|---|---|---|
| 3 | 2 | 1 | ||
| Total training time, min/day | 210 | 150 | 120 | Ergometer test—2,000 m |
| Time rowed, min/day | 70 | 90 | 100 | |
| Distance rowed, km/day | 16 | 18 | 20 | |
| Training for force development, min/day | 70 | |||
| Extensive endurance rowing training time, min/day | 40 | 90 | 100 | |
| High-intensity endurance rowing training time, min/day | 30 | |||
| Unspecific training (running, etc.), min/day | 70 | 60 | 20 | |
Changes in iron metabolism status during exhaustive exercise
| Variables | Pre-exercise M (± SD) | Post-exercise M (± SD) | Recovery M (± SD) |
|
|---|---|---|---|---|
| RBC, 1012/L | 5.29 (0.29) | 5.65 (0.30)a | 5.26 (0.30)c | 0.00000 |
| HGB, g/dL | 15.47 (0.67) | 16.54 (0.81)a | 15.34 (0.67)c | 0.00000 |
| HCT, % | 44.33 (1.95) | 48.23 (2.09)a | 43.99 (2.26)c | 0.00000 |
| MCV, fL | 85.78 (2.69) | 87.30 (2.87)a | 85.51 (2.79)c | 0.00000 |
| TIBC, µg/dL | 320.8 (32.83) | 352.2 (34.57)a | 325.5 (26.82)c | 0.00155 |
| UIBC, µg/dL | 175.0 (17.92) | 192.1 (18.87)a | 177.6 (14.66)c | 0.00155 |
| sTfR, µg/mL | 0.93 (0.14) | 1.26 (0.24)a | 0.93 (0.17)c | 0.00002 |
| Myoglobin, ng/mL | 245.2 (71.38) | 407.7 (131.21)a | 373.7 (104.86)b | 0.00026 |
RBC red blood cells, HGB hemoglobin, HCT hematocrit, MCV mean corpuscular volume, UIBC unsaturated iron-binding capacity, TIBC total iron-binding capacity, sTfR soluble transferrin receptor
aPre-exercise–post-exercise
bPre-exercise–recovery
cPost-exercise–recovery
Fig. 1Serum iron a, ferritin b, and hepcidin c levels in rowers at baseline, immediately after exercise, and after a 1-day recovery period. Data are presented as mean ± SEM. *Statistically significant difference between trials (p < 0.05)
Fig. 2Interleukin 6 a and tumor necrosis factor α b levels in rowers at baseline, immediately after exercise, and after a 1-day recovery period. Data are presented as mean ± SEM. *Statistically significant difference between trials (p < 0.05)
Fig. 3Creatine kinase levels at baseline, immediately after exercise, and after a 1-day recovery period. Data are presented as mean ± SEM. *Statistically significant difference between trials (p < 0.05)